In Bangladesh, where patriarchal norms and intimate partner violence shape the boundaries of women's lives, a single counseling session has demonstrated that reproductive autonomy is not beyond reach — even within constrained circumstances. The ARCHES intervention, tested through a cluster-randomized trial in clinics serving women seeking menstrual regulation and post-abortion care, significantly increased sustained contraceptive use twelve months after one focused conversation. What this trial quietly affirms is that when healthcare systems choose to see women as rights-bearing individuals ra
Counseling intervention boosts contraceptive use among Bangladesh women facing reproductive coercion
Women in Bangladesh experience high rates of intimate partner violence and reproductive coercion that restrict their reproductive autonomy and decision-making in healthcare.
A single counseling session helped women hold onto contraception despite partner opposition
Mark
So this is a counseling session—how long are we talking about? Is this a five-minute conversation or something more substantial?
Mimi
The source doesn't specify the exact duration, but it's described as a single session, which suggests it's designed to fit into a clinic visit without requiring women to come back for multiple appointments. The power seems to be in the focus and structure, not the length.
Luke
That's a gap worth naming. We know it worked, but we don't know how long it took or how much time providers had to spend. That matters for scalability.
Mark
And the outcome—continuous contraceptive use at twelve months. Does that mean they stayed on the same method, or just that they were using something?
Mimi
The source says "continuous contraceptive use," which typically means they didn't stop using contraception, but it doesn't specify whether they switched methods or stayed with the original one. The point is they maintained protection.
Luke
Right, and we should be careful not to overstate. The intervention increased the odds of continuous use, but we don't have the actual percentages from the source. We know it worked better than the control group, but not by how much.
Mark
What about the women who experienced the coercion—did any of them actually leave their partners or access the IPV services the counseling connected them to?
Mimi
The source doesn't report on that. It measures contraceptive use as the outcome, not whether women left relationships or used support services. Those are separate questions.
Luke
That's important. We're measuring a proxy—contraceptive use—not the underlying autonomy or safety. A woman could be using contraception while still being controlled. The intervention may be helping, but we shouldn't assume it solves the coercion itself.
Mark
The providers found it acceptable. Did any of them resist it or find it difficult to implement?
Mimi
The source says providers found it feasible and acceptable overall, and that provider motivation was a key factor in success. But it doesn't detail any resistance or implementation challenges.
Luke
Which means either there weren't significant barriers, or they weren't measured or reported. We know what worked, but not what didn't or what providers struggled with.
Mark
And this is Bangladesh-specific now, right? It was adapted from Kenya and the U.S. before that.
Mimi
Yes. The intervention was originally developed in the United States, then adapted for Kenya, and then adapted again for the Bangladesh context, specifically for women seeking menstrual regulation or post-abortion care. Each adaptation reflected local norms and healthcare systems.
Luke
Which raises a question the source doesn't answer: how much of the success is the intervention itself, and how much is the adaptation work that went into making it culturally appropriate? We know it worked in Bangladesh, but we don't know what made the Bangladesh version different from the Kenya version.
The Pulse
- Reproductive coercion — a partner or family member controlling contraception or pregnancy decisions — traps women in cycles of unintended pregnancy, and Bangladesh's high rates of intimate partner violence make this a pervasive and urgent crisis.
- ARCHES distills a complex problem into a single counseling session: helping women name the coercion they face, understand their rights, and access support — a modest intervention carrying an outsized burden of expectation.
- The trial found that providers delivered every component of the intervention with high fidelity, and women who received it were significantly more likely to still be using contraception a full year later, even against partner or family opposition.
- Provider motivation, training quality, and institutional backing emerged as the three pillars on which the intervention's effectiveness rested — remove any one, and the impact diminished.
- The intervention is proven; the unfinished work is scale — expanding clinic reach, ensuring referral pathways are real rather than nominal, and sustaining the conditions that made it work in the first place.
In Bangladesh, where patriarchal norms and intimate partner violence shape the boundaries of women's lives, a single counseling session has demonstrated that reproductive autonomy is not beyond reach — even within constrained circumstances. The ARCHES intervention, tested through a cluster-randomized trial in clinics serving women seeking menstrual regulation and post-abortion care, significantly increased sustained contraceptive use twelve months after one focused conversation. What this trial quietly affirms is that when healthcare systems choose to see women as rights-bearing individuals rather than family planning targets, the effects are measurable and lasting.
In Bangladesh, where intimate partner violence ranks among the world's highest and family structure often overrides women's healthcare decisions, a single counseling session is showing measurable power to change how women use contraception. The intervention — ARCHES, or Addressing Reproductive Coercion in Health Settings — was developed in the United States, tested in Kenya, and adapted for Bangladeshi clinics serving women seeking menstrual regulation or post-abortion care. Researchers wanted to know whether a focused conversation, held at a moment when women were already in a clinical setting, could help them sustain contraceptive use even when partners or family members opposed it.
Reproductive coercion is a form of gender-based violence that cycles women through unintended pregnancies by stripping them of control over their own bodies. A cluster-randomized controlled trial set out to measure whether ARCHES could interrupt that cycle. The intervention is deliberately modest: one counseling session designed to help women recognize coercion, understand their rights, and connect with available support services.
What researchers found was encouraging. Providers delivered all components of the intervention with high fidelity, and women who received it were significantly more likely to be using contraception twelve months later — even in the face of external opposition. Providers reported that the sessions were both feasible and useful, drawing women into deeper conversations about their own reproductive choices. Three factors determined success: provider motivation, quality of training, and institutional support. Where those conditions held, the intervention held.
The significance of this finding lies not only in what worked, but where. Bangladesh's healthcare system, like many in low- and middle-income countries, has historically treated women as targets for family planning rather than as individuals with agency. ARCHES centers the woman's own decision-making and explicitly names the violence that can surround reproductive choice. The trial demonstrated that when providers are trained and supported to have these conversations, women sustain contraceptive use — a concrete measure of reproductive autonomy preserved.
The next challenge is scale. Researchers identified that expanding the intervention requires optimizing how it spreads across more clinics, ensuring it aligns with what women actually need, and building referral pathways that are genuinely accessible. The intervention itself is proven; the work now is making sure it reaches the women who need it most.
In Bangladesh, where intimate partner violence ranks among the world's highest and patriarchal norms often override women's say in their own healthcare, a single counseling session is showing measurable power to shift how women use contraception. The intervention, called ARCHES—short for Addressing Reproductive Coercion in Health Settings—was born in the United States, tested in Kenya, and then adapted for Bangladeshi clinics serving women seeking menstrual regulation or post-abortion care. The question researchers wanted answered was straightforward: could a focused conversation, delivered at a moment when women were already in a healthcare setting, help them hold onto contraceptive use even when partners or family members opposed it?
Reproductive coercion—when a partner or family member controls or interferes with contraception, pregnancy, or childbearing decisions—is a form of gender-based violence that traps women in cycles of unintended pregnancy. In Bangladesh, where such coercion is common and deeply rooted in family structure, the stakes are high. Women lose autonomy over their own bodies and futures. A cluster-randomized controlled trial, registered in May 2018, set out to measure whether ARCHES could change that. The intervention itself is modest in scope: a single counseling session designed to help women recognize reproductive coercion, understand their rights, and connect with available support services for intimate partner violence.
The trial measured implementation fidelity—whether providers actually delivered the intervention as designed—and tracked whether women continued using contraception twelve months after the session. Researchers used a formal framework called CFIR (Consolidated Framework for Implementation Research) to assess how well the intervention fit into existing clinic workflows and what factors made it work. They also ran a sensitivity analysis to see whether the quality of delivery affected outcomes. What they found was encouraging: providers delivered all components of ARCHES with high fidelity, and women who received the full intervention were significantly more likely to be using contraception a year later, even in the face of partner or family opposition.
Providers themselves—the clinicians and counselors who delivered ARCHES—reported that the intervention was both feasible and acceptable. They found it useful for drawing clients into deeper conversation about their reproductive choices and for supporting women in making decisions that reflected their own needs rather than external pressure. The success hinged on three concrete factors: whether providers were motivated to deliver the intervention, whether they received quality training, and whether their institutions supported the work. Without those three elements, the intervention's power diminished.
What makes this finding significant is not just that a counseling session worked, but that it worked in a context where women's reproductive autonomy is systematically constrained. Bangladesh's healthcare system, like many in low- and middle-income countries, often treats women as vessels for family planning targets rather than as people with rights and agency. ARCHES, by contrast, centers the woman's own decision-making and explicitly names the violence that can surround reproductive choice. The trial showed that when providers are trained, supported, and motivated to have these conversations, women hold onto contraceptive use—a proxy for sustained reproductive autonomy.
The next phase is scaling. Researchers identified that success depends on three things: optimizing how the intervention spreads across more clinics, making sure it aligns with what women actually want and need, and building referral pathways that actually work in the local context. In other words, the intervention itself is proven; now the work is making sure it reaches the women who need it most, and that the support services it promises to connect them with are real and accessible.
Notable Quotes
Providers found the intervention feasible and acceptable, noting its usefulness in enhancing client engagement and supporting reproductive decision-making— Study evaluation results
Want the full story?
Read the original at Nature ↗
Health & Medicine